Related Experiment Videos
Extramammary Paget's disease: an annotated review.
L Balducci1, E D Crawford, G F Smith
1Division of Hematology Oncology, Jackson VA Medical Center, Mississippi.
Cancer Investigation
|January 1, 1988
Summary
Extramammary Paget's disease (EMPD) is a rare skin condition linked to underlying cancers and potential metastases. Originating from sweat glands, EMPD has a high recurrence rate after surgical excision.
Area of Science:
- Dermatology
- Oncology
- Pathology
Background:
- Extramammary Paget's disease (EMPD) is an uncommon neoplasm of the skin.
- It is frequently associated with underlying adnexal neoplasms or distant organ malignancies.
- EMPD possesses malignant potential, capable of metastasis even without a detectable primary cancer.
Purpose of the Study:
- To review the incidence, clinical features, histogenesis, and treatment of extramammary Paget's disease.
- To elucidate the cell of origin for EMPD.
- To assess current and potential treatment strategies for EMPD.
Main Methods:
- Review of existing literature on extramammary Paget's disease.
- Analysis of histochemical, immunohistological, and lectin binding studies.
- Evaluation of treatment outcomes, including surgical excision, chemosurgery, radiation therapy, and chemotherapy.
Main Results:
- EMPD is associated with underlying adnexal neoplasms in approximately 50% of cases.
- A higher than expected incidence of distant organ malignancies is observed in EMPD patients.
- Studies suggest EMPD originates from exocrine sweat gland cells, with apocrine derivation being more common than eccrine.
- Wide margin excision shows a high recurrence rate; chemosurgery may reduce local relapse.
- The efficacy of adjuvant radiation therapy is undetermined; chemotherapy has shown promise in advanced cases.
Conclusions:
- EMPD is a potentially malignant condition with diverse origins and associations.
- Effective management requires addressing both the primary lesion and potential underlying or metastatic disease.
- Further clinical trials are needed to establish optimal treatment protocols, particularly for chemotherapy.